title: [EXPERIMENTAL PHARMACOKINETICS AND PHARMACODYNAMICS OF GB-115 DIPEPTIDE ANXIOLYTIC SUBSTANCES].
abstract: Pharmacokinetics and pharmacological activity of GB-115 dipeptide anxiolytic after oral administration in the form of crystalline and micronized substances was studied in albino male rats. In contrast to crystalline, the micronized substance exhibited better pharmacokinetic parameters and higher bioavailability. In the "elevated plus maze" test, GB-115 in micronized form at a dose 0.3 mg/kg demonstrated pronounced anxiolytic properties during prolonged period as compared to crystalline substance at the same dose. The obtained data allow the micronized substance of GB-115 to be recommended for inclusion in pharmaceutical composition of new dipeptide anxiolytic drug formulations.
authors.forename: L G
authors.initials: LG
authors.lastname: Kolik
authors.forename: V P
authors.initials: VP
authors.lastname: Zherdev
authors.forename: S S
authors.initials: SS
authors.lastname: Boiko
authors.forename: M A
authors.initials: MA
authors.lastname: Konstantinopol'skii
authors.forename: S Yu
authors.initials: SY
authors.lastname: Raskin
authors.forename: T A
authors.initials: TA
authors.lastname: Gudasheva
authors.forename: V A
authors.initials: VA
authors.lastname: Mart'yanov
authors.forename: S B
authors.initials: SB
authors.lastname: Seredenin
mesh_terms: D000818:Animals; D014151:Anti-Anxiety Agents / Q000493:pharmacokinetics* / Q000494:pharmacology*; D004151:Dipeptides / Q000493:pharmacokinetics* / Q000494:pharmacology*; D008297:Male; D018782:Maze Learning / Q000187:drug effects*; D051381:Rats
chemical_list: D014151:Anti-Anxiety Agents; D004151:Dipeptides; C520797:GB-115